A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy

Immunology

Volumn 131, Issue 3, 2010, Pages 405-414

  Ochoa, Maria T ^a   Teles, Rosane ^a   Haas, Blake E ^a   Zaghi, Danny ^b   Li, Huiying ^a   Sarno, Euzenir N ^c   Rea, Thomas H ^d   Modlin, Robert L ^a,e   Lee, Delphine J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cells; Immunoglobulin; Interleukin 5; Leprosy

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 5;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; LEPROMATOUS LEPROSY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN DEFECT; TUBERCULOID LEPROSY;

B-LYMPHOCYTES; BIOPSY; CELLS, CULTURED; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-5; LEPROSY; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM LEPRAE; SKIN; SYNDECAN-1; TH2 CELLS; TUBERCULOSIS, PULMONARY;

EID: 78649414414     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03314.x     Document Type: Article

References (39)

1. Ridley DS, Jopling WH. Classification of leprosy according to immunity A five-group system. Int J Lepr 1966; 34:255-73.
2. Cooper CL, Mueller C, Sinchaisri T-A et al. Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med 1989; 169:1565-81.
3. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
4. Yamamura M, Wang X-H, Ohmen JD et al. Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992; 149:1470-5.
5. Sieling PA, Abrams JS, Yamamura M et al. Immunosuppressive roles for interleukin-10 and interleukin-4 in human infection: in vitro modulation of T cell responses in leprosy. J Immunol 1993; 150:5501-10.
6. Libraty DH, Airan LE, Uyemura K et al. Interferon-γ differentially regulates interleukin-12 and interleukin-10 production in leprosy. J Clin Invest 1997; 99:336-41.
7. Murphy GF, Sanchez NP, Flynn TC, Sanchez JL, Mihm MC Jr, Soter NA. Erythema nodosum leprosum: nature and extent of the cutaneous microvascular alterations. J Am Acad Dermatol 1986; 14:59-69.
8. Wemambu SNC, Turk JL, Waters MFR, Rees RJW. Erythema nodosum leprosum: a clinical manifestation of the Arthus phenomenon. Lancet 1969; 2:933-5.
9. Ridley MJ, Ridley DS. The immunopathology of erythema nodosum leprosum: the role of extravascular complexes. Lepr Rev 1983; 54:95-107.
10. Bleharski JR, Li H, Meinken C et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003; 301:1527-30.
11. Modlin RL, Hofman FM, Horwitz DA et al. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol 1984; 132:3085-90.
12. Ochoa MT, Stenger S, Sieling PA et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001; 7:174-9.
13. Hussain R, Lucas SB, Kifayet A et al. Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP. Int J Lepr 1995; 63:222-30.
14. Hussain R, Dockrell HM, Chiang TJ. Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy 6. Immunology 1999; 96:620-7.
15. Matsumoto R, Matsumoto M, Mita S et al. Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells. Immunology 1989; 66:32-8.
16. McIntyre TM, Kehry MR, Snapper CM. Novel in vitro model for high-rate IgA class switching. J Immunol 1995; 154:3156-61.
17. Coffman RL, Lebman DA, Shrader B. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989; 170:1039-44.
18. Sonoda E, Matsumoto R, Hitoshi Y et al. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 1989; 170:1415-20.
19. Mizoguchi C, Uehara S, Akira S, Takatsu K. IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgD-positive B lymphocytes. J Immunol 1999; 162:2812-19.
20. Bertolini JN, Sanderson CJ, Benson EM. Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM. Eur J Immunol 1993; 23:398-402.
21. Morikawa K, Oseko F, Morikawa S, Imai K, Sawada M. Recombinant human IL-5 augments immunoglobulin generation by human B lymphocytes in the presence of IL-2. Cell Immunol 1993; 149:390-401.
22. Ridley DS. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ 1974; 51:451-65.
23. Iyer AM, Mohanty KK, Van ED et al. Leprosy-specific B-cells within cellular infiltrates in active leprosy lesions. Hum Pathol 2007; 38:1065-73.
24. Casadevall A. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun 2003; 71:4225-8.
25. Vordermeier HM, Venkataprasad N, Harris DP, Ivanyi J. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol 1996; 106:312-16.
26. Loizou S, Singh S, Wypkema E, Asherson RA. Anticardiolipin, anti-β(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 2003; 62:1106-11.
27. Guedes Barbosa LS, Gilbrut B, Shoenfeld Y, Scheinberg MA. Autoantibodies in leprosy sera. Clin Rheumatol 1996; 15:26-8.
28. De Larranaga GF, Forastiero RR, Martinuzzo ME et al. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 2000; 9:594-600.
29. Vengadakrishnan K, Saraswat PK, Mathur PC. A study of rheumatological manifestations of leprosy. Indian J Dermatol Venereol Leprol 2004; 70:76-8.
30. Anthony J, Vaidya MC, Dasgupta A. Ultrastructure of skin in erythema nodosum leprosum. Cytobios 1983; 36:17-23.
31. Waters MF, Rees RJ, Sutherland I. Chemotherapeutic trials in leprosy. 5 A study of methods used in clinical trials in lepromatous leprosy. Int J Lepr Other Mycobact Dis 1967; 35:311-35.
32. Nagao-Dias AT, Almeida TL, Oliveira MF, Santos RC, Lima AL, Brasil M. Salivary anti-PGL IgM and IgA titers and serum antibody IgG titers and avidities in leprosy patients and their correlation with time of infection and antigen exposure. Braz J Infect Dis 2007; 11:215-19.
33. Scollard DM, Bhoopat L, Kestens L, Vanham G, Douglas JT, Moad J. Immune complexes and antibody levels in blisters over human leprosy skin lesions with or without erythema nodosum leprosum. Clin Immunol Immunopathol 1992; 63:230-6.
34. Van Epps DE, Williams RC Jr. Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med 1976; 144:1227-42.
35. Wolf HM, Hauber I, Gulle H et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc α R (CD89)-mediated down-regulation of tumour necrosis factor-α (TNF-α) and IL-6 in human monocytes. Clin Exp Immunol 1996; 105:537-43.
36. Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. Anti-inflammatory role for intracellular dimeric immunoglobulin A by neutralization of lipopolysaccharide in epithelial cells. Immunity 2003; 18:739-49.
37. Olas K, Butterweck H, Teschner W, Schwarz HP, Reipert B. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin Exp Immunol 2005; 140:478-90.
38. Patry C, Herbelin A, Lehuen A, Bach JF, Monteiro RC. Fc α receptors mediate release of tumour necrosis factor-α and interleukin-6 by human monocytes following receptor aggregation. Immunology 1995; 86:1-5.
39. Wu J, Ji C, Xie F et al. FcαRI (CD89) alleles determine the proinflammatory potential of serum IgA. J Immunol 2007; 178:3973-82.